- Home
- STR vs AMPH Comparison
STR vs AMPH Comparison
Compare STR & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STR
- AMPH
- Stock Information
- Founded
- STR 2016
- AMPH 1996
- Country
- STR United States
- AMPH United States
- Employees
- STR N/A
- AMPH N/A
- Industry
- STR Oil & Gas Production
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- STR Energy
- AMPH Health Care
- Exchange
- STR Nasdaq
- AMPH Nasdaq
- Market Cap
- STR 1.4B
- AMPH 1.1B
- IPO Year
- STR N/A
- AMPH 2014
- Fundamental
- Price
- STR $18.40
- AMPH $23.20
- Analyst Decision
- STR Buy
- AMPH Hold
- Analyst Count
- STR 6
- AMPH 5
- Target Price
- STR $25.40
- AMPH $38.00
- AVG Volume (30 Days)
- STR 1.5M
- AMPH 493.6K
- Earning Date
- STR 08-06-2025
- AMPH 08-06-2025
- Dividend Yield
- STR 7.60%
- AMPH N/A
- EPS Growth
- STR N/A
- AMPH N/A
- EPS
- STR 0.52
- AMPH 2.77
- Revenue
- STR $636,538,000.00
- AMPH $730,659,000.00
- Revenue This Year
- STR N/A
- AMPH $0.67
- Revenue Next Year
- STR N/A
- AMPH $5.18
- P/E Ratio
- STR $35.36
- AMPH $8.39
- Revenue Growth
- STR 7.18
- AMPH 8.05
- 52 Week Low
- STR $14.58
- AMPH $22.64
- 52 Week High
- STR $25.64
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- STR 47.03
- AMPH 37.07
- Support Level
- STR $18.12
- AMPH $22.81
- Resistance Level
- STR $18.75
- AMPH $24.52
- Average True Range (ATR)
- STR 0.50
- AMPH 0.74
- MACD
- STR -0.17
- AMPH -0.22
- Stochastic Oscillator
- STR 16.73
- AMPH 11.27
About STR Sitio Royalties Corp.
Sitio Royalties Corp is a pure-play mineral and royalty company. The group focuses on investing in mineral and royalty interests in the Permian and other productive U.S. oil basins.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.